Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Accuray Inc (NASDAQ:ARAY)

Delayed Data
As of Sep 19
 +0.05 / +1.11%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Accuray, Inc. is the premier radiation oncology company which develops, manufactures and sells personalized treatment solutions such as the cyberKnife and tomotherapy systems, which are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The cyberKnife system is designed to combine continual image guidance technology with a compact linear accelerator, or linac, which has the ability to move in three dimensions according to the treatment plan. The tomotherapy system operates on a ring gantry and combines integrated computed tomography, or CT, imaging with intensity modulated radiation therapy, which is designed to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. Accuray was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Contact Information

Accuray, Inc.
1310 Chesapeake Terrace
Sunnyvale California 94089
P:(408) 716-4600
Investor Relations:
(408) 789-4335



Mutual fund holders46.83%
Other institutional35.83%
Individual stakeholders30.45%

Top Executives

Joshua H. LevinePresident, Chief Executive Officer & Director
Kevin WatersChief Financial Officer & Senior Vice President
Robert W. HillSenior Vice President-Research & Development
Darl S. MorelandSenior VP-Regulatory, Quality & Compliance
Alaleh NouriSecretary, Senior Vice President & General Counsel